SCHEMBL8758915

SCHEMBL8758915

O[C@H]1CCCN2CCC[C@@H]12

nearest known ligand 0.70

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ SLC18A3 Q16572 12/20 0.70
▸ CYP2D6 P10635 2/20 0.52
▸ TSHR P16473 2/20 0.52
▸ SMN1; SMN2 Q16637 2/20 0.52
▸ CYP1A2 P05177 1/20 0.52
▸ CYP2C9 P11712 1/20 0.52
▸ SIGMAR1 Q99720 1/20 0.52
▸ ALDH1A1 P00352 1/20 0.50
▸ APEX1 P27695 1/20 0.50
▸ BLM P54132 1/20 0.50
▸ MAN2B1 O00754 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8758924 1.00 SLC18A3 (0.70) SLC18A3CYP2D6TSHRSMN1; SMN2CYP1A2
SCHEMBL8758920 1.00 SLC18A3 (0.70) SLC18A3CYP2D6TSHRSMN1; SMN2CYP1A2
SCHEMBL2103211 0.95 SLC18A3 (0.71) SLC18A3CYP2D6TSHRSMN1; SMN2CYP1A2
SCHEMBL15448034 0.95 SLC18A3 (0.71) SLC18A3CYP2D6TSHRSMN1; SMN2CYP1A2
SCHEMBL25368949 0.92 SLC18A3 (0.67) SLC18A3CYP2D6TSHRSMN1; SMN2CYP1A2
SCHEMBL14367947 0.92 SLC18A3 (0.74) SLC18A3CYP2D6TSHRSMN1; SMN2CYP1A2
SCHEMBL4488180 0.92 SLC18A3 (0.74) SLC18A3CYP2D6TSHRSMN1; SMN2CYP1A2
SCHEMBL8989794 0.92 SLC18A3 (0.74) SLC18A3CYP2D6TSHRSMN1; SMN2CYP1A2
SCHEMBL17286254 0.92 SLC18A3 (0.74) SLC18A3CYP2D6TSHRSMN1; SMN2CYP1A2
SCHEMBL25305403 0.92 SLC18A3 (0.74) SLC18A3CYP2D6TSHRSMN1; SMN2CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0774256-A1 Use of azacyclic or azabicyclic thiadiazole compounds for treating anxiety ELI LILLY AND COMPANY (US) 1997-05-21 — — EP disclosed
EP-0709381-A1 Heterocyclic compounds and their preparation and use ELI LILLY AND COMPANY (US) 1996-05-01 — — EP disclosed
Send feedback